The Benefits of Writing a Monthly Column About EB
In the spring of 2018, I was lucky enough to meet a member of the Bionews team (the parent company of Epidermolysis Bullosa News) at the European Conference on Rare Diseases and Orphan Products in Vienna. Brad, the director of columns, asked me if I was interested in…